-
1
-
-
75749118959
-
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
-
Peters MJ, Symmons DP, McCarey D, et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2010; 69: 325-31.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 325-331
-
-
Peters, M.J.1
Symmons, D.P.2
McCarey, D.3
-
2
-
-
33846998295
-
HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis
-
Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ, et al. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum 2007; 57: 125-32.
-
(2007)
Arthritis Rheum
, vol.57
, pp. 125-132
-
-
Gonzalez-Gay, M.A.1
Gonzalez-Juanatey, C.2
Lopez-Diaz, M.J.3
-
3
-
-
69249222895
-
Role for TNF in atherosclerosis? Lessons from autoimmune disease
-
McKellar GE, McCarey DW, Sattar N, et al. Role for TNF in atherosclerosis? Lessons from autoimmune disease. Nat Rev Cardiol 2009; 6: 410-17.
-
(2009)
Nat Rev Cardiol
, vol.6
, pp. 410-417
-
-
McKellar, G.E.1
McCarey, D.W.2
Sattar, N.3
-
4
-
-
0346365086
-
Explaining how 'high-grade' systemic inflammation accelerates vascular risk in rheumatoid arthritis
-
Sattar N, McCarey DW, Capell H, et al. Explaining how 'high-grade' systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003; 108: 2957-63.
-
(2003)
Circulation
, vol.108
, pp. 2957-2963
-
-
Sattar, N.1
McCarey, D.W.2
Capell, H.3
-
5
-
-
0035676862
-
Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: Possible contribution of phospholipase A2 to this atherogenic profile
-
Hurt-Camejo E, Paredes S, Masana L, et al. Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: Possible contribution of phospholipase A2 to this atherogenic profile. Arthritis Rheum 2001; 44: 2761-67.
-
(2001)
Arthritis Rheum
, vol.44
, pp. 2761-2767
-
-
Hurt-Camejo, E.1
Paredes, S.2
Masana, L.3
-
6
-
-
77955478708
-
Lipoprotein subclasses determined by nuclear magnetic resonance spectroscopy and coronary atherosclerosis in patients with rheumatoid arthritis
-
Chung CP, Oeser A, Raggi P, et al. Lipoprotein subclasses determined by nuclear magnetic resonance spectroscopy and coronary atherosclerosis in patients with rheumatoid arthritis. J Rheumatol 2010; 37: 1633-8.
-
(2010)
J Rheumatol
, vol.37
, pp. 1633-1638
-
-
Chung, C.P.1
Oeser, A.2
Raggi, P.3
-
7
-
-
64949111191
-
Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: A challenge to conventional cardiovascular risk actions
-
Choy E, Sattar N. Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: A challenge to conventional cardiovascular risk actions. Ann Rheum Dis 2009; 68: 460-9.
-
(2009)
Ann Rheum Dis
, vol.68
, pp. 460-469
-
-
Choy, E.1
Sattar, N.2
-
8
-
-
33746095378
-
Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease
-
Packard CJ. Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease. Curr Opin Lipidol 2006; 17: 412-17.
-
(2006)
Curr Opin Lipidol
, vol.17
, pp. 412-417
-
-
Packard, C.J.1
-
9
-
-
3042606551
-
Effects of infection and inflammation on lipid and lipoprotein metabolism: Mechanisms and consequences to the host
-
Khovidhunkit W, Kim MS, Memon RA, et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: Mechanisms and consequences to the host. J Lipid Res 2004; 45: 1169-96.
-
(2004)
J Lipid Res
, vol.45
, pp. 1169-1196
-
-
Khovidhunkit, W.1
Kim, M.S.2
Memon, R.A.3
-
10
-
-
73549097512
-
Genetic variants associated with Lp(a) lipoprotein level and coronary disease
-
Clarke R, Peden JF, Hopewell JC, et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med 2009; 361: 2518-28.
-
(2009)
N Engl J Med
, vol.361
, pp. 2518-2528
-
-
Clarke, R.1
Peden, J.F.2
Hopewell, J.C.3
-
11
-
-
70350033694
-
Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men
-
Wannamethee SG, Whincup PH, Shaper AG, et al. Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men. J Thromb Haemost 2009; 7: 1605-11.
-
(2009)
J Thromb Haemost
, vol.7
, pp. 1605-1611
-
-
Wannamethee, S.G.1
Whincup, P.H.2
Shaper, A.G.3
-
12
-
-
77953980528
-
IL-6: From its discovery to clinical applications
-
Kishimoto T. IL-6: From its discovery to clinical applications. Int Immunol 2010; 22: 347-52.
-
(2010)
Int Immunol
, vol.22
, pp. 347-352
-
-
Kishimoto, T.1
-
13
-
-
67650217953
-
Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?
-
Sattar N, Murray HM, Welsh P, et al. Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?. PLoS Med 2009; 6: E1000099.
-
(2009)
PLoS Med
, vol.6
, pp. e1000099
-
-
Sattar, N.1
Murray, H.M.2
Welsh, P.3
-
14
-
-
43249118045
-
Long-Term interleukin-6 levels and subsequent risk of coronary heart disease: Two new prospective studies and a systematic review
-
Danesh J, Kaptoge S, Mann AG, et al. Long-Term interleukin-6 levels and subsequent risk of coronary heart disease: Two new prospective studies and a systematic review. PLoS Med 2008; 5: E78.
-
(2008)
PLoS Med
, vol.5
, pp. e78
-
-
Danesh, J.1
Kaptoge, S.2
Mann, A.G.3
-
15
-
-
79956319051
-
Progress and challenges in translating the biology of atherosclerosis
-
Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature 2011; 473: 317-25.
-
(2011)
Nature
, vol.473
, pp. 317-325
-
-
Libby, P.1
Ridker, P.M.2
Hansson, G.K.3
-
16
-
-
84859215358
-
The interleukin-6 receptor as a target for prevention of coronary heart disease: A Mendelian randomisation analysis
-
Interleukin 6 Receptor Mendelian Randomisation Analysis (IL6R MR) ConsortiumHingorani AD, Casas JP. The interleukin-6 receptor as a target for prevention of coronary heart disease: A Mendelian randomisation analysis. Lancet 2012; 379: 1214-24.
-
(2012)
Lancet
, vol.379
, pp. 1214-1224
-
-
Hingorani, A.D.1
Casas, J.P.2
-
17
-
-
84859210770
-
Interleukin-6 receptor pathways in coronary heart disease: A collaborative meta-Analysis of 82 studies
-
IL6R Genetics Consortium Emerging Risk Factors CollaborationSarwar N, Butterworth AS, et al. Interleukin-6 receptor pathways in coronary heart disease: A collaborative meta-Analysis of 82 studies. Lancet 2012; 379: 1205-13.
-
(2012)
Lancet
, vol.379
, pp. 1205-1213
-
-
Sarwar, N.1
Butterworth, A.S.2
-
18
-
-
33748644710
-
Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-Tumor necrosis factor-Alpha therapy
-
Mäki-Petäjä KM, Hall FC, Booth AD, et al. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-Tumor necrosis factor-Alpha therapy. Circulation 2006; 114: 1185-92.
-
(2006)
Circulation
, vol.114
, pp. 1185-1192
-
-
Mäki-Petäjä, K.M.1
Hall, F.C.2
Booth, A.D.3
-
19
-
-
33750318148
-
Expert consensus document on arterial stiffness: Methodological issues and clinical applications
-
Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: Methodological issues and clinical applications. Eur Heart J 2006; 27: 2588-605.
-
(2006)
Eur Heart J
, vol.27
, pp. 2588-2605
-
-
Laurent, S.1
Cockcroft, J.2
Van Bortel, L.3
-
20
-
-
79951739491
-
Interleukin-6 inhibition for treatment of rheumatoid arthritis: A review of tocilizumab therapy
-
Patel AM, Moreland LW. Interleukin-6 inhibition for treatment of rheumatoid arthritis: A review of tocilizumab therapy. Drug Design Dev Ther 2010; 4: 263-78.
-
(2010)
Drug Design Dev Ther
, vol.4
, pp. 263-278
-
-
Patel, A.M.1
Moreland, L.W.2
-
21
-
-
80053483450
-
Tocilizumab monotherapy reduces arterial stiffness as effectively as etanercept or adalimumab monotherapy in rheumatoid arthritis: An open-label randomized controlled trial
-
Kume K, Amano K, Yamada S, et al. Tocilizumab monotherapy reduces arterial stiffness as effectively as etanercept or adalimumab monotherapy in rheumatoid arthritis: An open-label randomized controlled trial. J Rheumatol 2011; 38: 2169-71.
-
(2011)
J Rheumatol
, vol.38
, pp. 2169-2171
-
-
Kume, K.1
Amano, K.2
Yamada, S.3
-
22
-
-
66049109843
-
Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: A prospective cohort study in ankylosing spondylitis
-
van Eijk IC, de Vries MK, Levels JH, et al. Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: A prospective cohort study in ankylosing spondylitis. Arthritis Rheum 2009; 60: 1324-30.
-
(2009)
Arthritis Rheum
, vol.60
, pp. 1324-1330
-
-
Van Eijk, I.C.1
De Vries, M.K.2
Levels, J.H.3
-
23
-
-
0141885327
-
Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress
-
Kontush A, Chantepie S, Chapman MJ. Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress. Arterioscler Thromb Vasc Biol 2003; 23: 1881-8.
-
(2003)
Arterioscler Thromb Vasc Biol
, vol.23
, pp. 1881-1888
-
-
Kontush, A.1
Chantepie, S.2
Chapman, M.J.3
-
24
-
-
77950335656
-
Overproduced interleukin 6 decreases blood lipid levels via upregulation of very-low-density lipoprotein receptor
-
Hashizume M, Yoshida H, Koike N, et al. Overproduced interleukin 6 decreases blood lipid levels via upregulation of very-low-density lipoprotein receptor. Ann Rheum Dis 2010; 69: 741-6.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 741-746
-
-
Hashizume, M.1
Yoshida, H.2
Koike, N.3
-
25
-
-
0033927969
-
Interleukin-6 stimulates LDL receptor gene expression via activation of sterol-responsive and Sp1 binding elements
-
Gierens H, Nauck M, Roth M, et al. Interleukin-6 stimulates LDL receptor gene expression via activation of sterol-responsive and Sp1 binding elements. Arterioscler Thromb Vasc Biol 2000; 20: 1777-83.
-
(2000)
Arterioscler Thromb Vasc Biol
, vol.20
, pp. 1777-1783
-
-
Gierens, H.1
Nauck, M.2
Roth, M.3
-
26
-
-
84860331375
-
Atherogenic effects of TNF-A and IL-6 via up-regulation of scavenger receptors
-
Hashizume M, Mihara M. Atherogenic effects of TNF-A and IL-6 via up-regulation of scavenger receptors. Cytokine 2012; 58: 424-30.
-
(2012)
Cytokine
, vol.58
, pp. 424-430
-
-
Hashizume, M.1
Mihara, M.2
-
27
-
-
0036511148
-
Changes in the concentration and composition of plasma lipoproteins during the acute phase response
-
Carpentier YA, Scruel O. Changes in the concentration and composition of plasma lipoproteins during the acute phase response. Curr Opin Clin Nutr Metab Care 2002; 5: 153-8.
-
(2002)
Curr Opin Clin Nutr Metab Care
, vol.5
, pp. 153-158
-
-
Carpentier, Y.A.1
Scruel, O.2
-
28
-
-
0032974070
-
Fibrinolytic activation markers predict myocardial infarction in the elderly: The Cardiovascular Health Study
-
Cushman M, Lemaitre RN, Kuller LH, et al. Fibrinolytic activation markers predict myocardial infarction in the elderly: The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1999; 19: 493-8.
-
(1999)
Arterioscler Thromb Vasc Biol
, vol.19
, pp. 493-498
-
-
Cushman, M.1
Lemaitre, R.N.2
Kuller, L.H.3
-
29
-
-
0035873876
-
Fibrin D-dimer and coronary heart disease: Prospective study and meta-Analysis
-
Danesh J, Whincup P, Walker M, et al. Fibrin D-dimer and coronary heart disease: Prospective study and meta-Analysis. Circulation 2001; 103: 2323-7.
-
(2001)
Circulation
, vol.103
, pp. 2323-2327
-
-
Danesh, J.1
Whincup, P.2
Walker, M.3
-
30
-
-
67651210632
-
Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality
-
Emerging Risk Factors CollaborationErqou S, Kaptoge S, et al. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 2009; 302: 412-23.
-
(2009)
JAMA
, vol.302
, pp. 412-423
-
-
Erqou, S.1
Kaptoge, S.2
-
31
-
-
33947098982
-
Effects of tumor necrosis factor blockade on cardiovascular risk factors in psoriatic arthritis: A double-blind, placebo-controlled study
-
Sattar N, Crompton P, Cherry L, et al. Effects of tumor necrosis factor blockade on cardiovascular risk factors in psoriatic arthritis: A double-blind, placebo-controlled study. Arthritis Rheum 2007; 56: 831-9.
-
(2007)
Arthritis Rheum
, vol.56
, pp. 831-839
-
-
Sattar, N.1
Crompton, P.2
Cherry, L.3
|